⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29391663 | 0.75 | — | — | |
| SCHEMBL29398110 | 0.75 | — | — | |
| SCHEMBL29610082 | 0.75 | — | — | |
| SCHEMBL190657 | 0.75 | — | — | |
| SCHEMBL7050547 | 0.75 | — | — | |
| SCHEMBL30151389 | 0.75 | — | — | |
| SCHEMBL655268 | 0.75 | — | — | |
| SCHEMBL338633 | 0.75 | — | — | |
| SCHEMBL109855 | 0.75 | — | — | |
| SCHEMBL1428398 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 308 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118767991-A | Catalyst, preparation method thereof and application of catalyst in cyclododecanone synthesis | 万华化学集团股份有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-115341388-A | Preparation method of non-ironing antistatic anti-pilling polyester-cotton blended fabric | 湖州纳尼亚实业有限公司 | 2022-11-15 | — | — | CN | claimed |
| CN-110343074-B | Synthesis method of 2-amino-4-chloro-5-fluoropyrimidine | 南京普锐达医药科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| US-20140187777-A1 | MATERIALS AND METHODS FOR THE BASE-ASSISTED SYNTHESIS OF SUBSTITUTED HETEROAROMATIC COMPOUNDS | DOW AGROSCIENCES LLC (US) | 2014-07-03 | — | — | US | claimed |
| WO-2013148512-A1 | MATERIALS AND METHODS FOR THE BASE-ASSISTED SYNTHESIS OF SUBSTITUTED HETEROAROMATICS | DOW AGROSCIENCES LLC (US) | 2013-10-03 | — | — | WO | claimed |
| JP-8127569-A | — | — | None | — | — | JP | disclosed |
| US-20260146124-A1 | RESIN COMPOSITION AND USES OF THE SAME | TAIWAN UNION TECHNOLOGY CORPORATION (TW) | 2026-05-28 | — | — | US | disclosed |
| US-20260085154-A1 | POLYMER, COMPOSITION, CURED PRODUCT, LAMINATED BODY, AND ELECTRONIC COMPONENT | JSR CORPORATION (JP) | 2026-03-26 | — | — | US | disclosed |
| EP-4709723-A1 | ISOXAZOLIDINES AS RIPK1 INHIBITORS AND USE THEREOF | GENZYME CORPORATION (US) | 2026-03-18 | — | — | EP | disclosed |
| EP-4658662-A1 | MACROCYCLIC AMINOPYRIDINE COMPOUNDS AS EGFR INHIBITORS | Yuhan Corporation (KR) | 2025-12-10 | — | — | EP | disclosed |
| US-20250365860-A1 | COPPER-CLAD LAMINATE AND USES OF THE SAME | TAIWAN UNION TECHNOLOGY CORP (TW) | 2025-11-27 | — | — | US | disclosed |
| EP-4652161-A1 | 2,4-DIANILINOPYRIMIDINE-BASED AURORA-A KINASE SELECTIVE DEGRADATION INDUCING COMPOUNDS | Uppthera, Inc. (KR) | 2025-11-26 | — | — | EP | disclosed |
| EP-1066286-A1 | HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2001-01-10 | — | — | EP | disclosed |
| US-5990109-A | NOVEL COMPOUNDS, METHODS OF THEIR SYNTHESIS, AND THEIR USE IN TREATING VARIOUS TYROSINE KINASE-ASSOCIATED IMMUNOLOGICAL DISORDERS, SUCH AS RHEUMATOID ARTHRITIS, MULTIPLE SCLEROSIS, GRAFT VS. HOST DISEASE, LUPUS, PSORIASIS AND ASTHMA | BRISTOL-MYERS SQUIBB CO. (US) | 1999-11-23 | — | — | US | disclosed |
| WO-1999045009-A1 | HETEROCYCLO-SUBSTITUTED IMIDAZOPYRAZINE PROTEIN TYROSINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-09-10 | — | — | WO | disclosed |
| EP-0532178-B1 | Methanoanthracenes as dopamine antagonists | ZENECA LTD (GB) | 1996-10-16 | — | — | EP | disclosed |
| JP-H08127569-A | PRODUCTION OF FLUCYTOSINE | SUMIKA FINE CHEM KK | 1996-05-21 | — | — | JP | disclosed |
| US-5455246-A | Treating neuropsychiatric disorders | IMPERIAL CHEMICAL INDUSTRIES, PLC (GB) | 1995-10-03 | — | — | US | disclosed |
| US-5266570-A | Neuropsychiatric disorders | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1993-11-30 | — | — | US | disclosed |
| EP-0532178-A1 | Methanoanthracenes as dopamine antagonists | ZENECA LIMITED (GB) | 1993-03-17 | — | — | EP | disclosed |